INCOME TAXES - Schedule of Income Tax Rate Reconciliation Amount (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | 9 Months Ended | 12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2023 |
Sep. 30, 2023 |
Jun. 30, 2023 |
Dec. 31, 2022 |
Sep. 30, 2022 |
Jun. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
Dec. 31, 2023 |
Dec. 31, 2022 |
Mar. 31, 2024 |
Mar. 31, 2023 |
Mar. 31, 2022 |
|
| Income Tax Disclosure [Abstract] | |||||||||||||
| Federal statutory rate (as a percent) | 21.00% | ||||||||||||
| Expense (benefit) at the federal statutory rate | $ (8,507) | $ (3,450) | $ 8,341 | ||||||||||
| Equity compensation | 1,102 | 1,945 | 195 | ||||||||||
| Permanent items | 768 | 1,498 | 1,941 | ||||||||||
| Foreign taxes | 264 | 586 | 1,761 | ||||||||||
| State income taxes | (860) | (124) | (133) | ||||||||||
| Valuation allowance | 6,313 | 2,890 | (7,396) | ||||||||||
| Uncertain tax positions | (8,010) | (3,791) | (6,349) | ||||||||||
| Credit monetization | 0 | 0 | (2,100) | ||||||||||
| Expiration of attributes | 10,901 | 5,733 | 18,345 | ||||||||||
| Research and development credits | (1,169) | (1,582) | (2,094) | ||||||||||
| Warrant fair value adjustments | (1,093) | (2,152) | (12,606) | ||||||||||
| Other | 1,002 | 387 | 1,436 | ||||||||||
| Income tax provision | $ 510 | $ 533 | $ 530 | $ 693 | $ 461 | $ 410 | $ 1,063 | $ 872 | $ 1,573 | $ 1,564 | $ 711 | $ 1,940 | $ 1,341 |
| X | ||||||||||
- Definition Effective Income Tax Rate Reconciliation, Derivative Instrument Adjustments No definition available.
|
| X | ||||||||||
- Definition Effective Income Tax Rate Reconciliation, Expiration Of Attributes, Amount No definition available.
|
| X | ||||||||||
- Definition Effective Income Tax Rate Reconciliation, Uncertain Tax Positions, Amount No definition available.
|
| X | ||||||||||
- Definition Income Tax Reconciliation, Credit Monetization No definition available.
|
| X | ||||||||||
- Definition Percentage of domestic federal statutory tax rate applicable to pretax income (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|